Lusutrombopag in the Treatment of Immune Thrombocytopenia (ITP) - NCT06287567

Summary

Status & Type
    Key Dates
      Lead Sponsor

      Conditions
        Interventions
          Arm Group Labels
            Primary Outcomes
              GreyB © 2025 Elixir. All rights reserved.